未登录

Y

Yuan Fu

天津医科大学

H指数:17

被引数:1,129

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

SelO-mediated nicotinamide adenine dinucleotide hydrolysis and its implications for metabolic therapies

SelO介导的烟酰胺腺嘌呤二核苷酸水解及其对代谢疗法的意义

Clinical and Translational Medicine

IF6.8

2026-08-100

OAAI

From inactivation to intervention: X chromosome silencing in disease pathogenesis and emerging therapeutic strategies

付，Y.; 谭，X.; 秦，L.; 王，C. 从失活到干预：X染色体沉默在疾病发生机制及新兴治疗策略中的作用。Genes Dis. 2025; 在印刷中。 [CrossRef]

Genes & Diseases

IF9.4

2025-12-050

OAAI

Fam72a functions as a cell-cycle-controlled gene during proliferation and antagonizes apoptosis through reprogramming PP2A substrates

DEVELOPMENTAL CELL

IF8.7

2023-03-016

OA

Nuclear Fructose-1,6-Bisphosphate Inhibits Tumor Growth and Sensitizes Chemotherapy by Targeting HMGB1

ADVANCED SCIENCE

IF14.1

2023-01-1520

OA

Psychiatric symptoms before and after COVID-19 vaccination: A cohort study of hospitalized schizophrenia patients

ASIAN JOURNAL OF PSYCHIATRY

IF4.5

2022-12-014

OAAI

Discoidin domain receptor 1 is a potential target correlated with tumor invasion and immune infiltration in gastric cancer

FRONTIERS IN IMMUNOLOGY

IF5.9

2022-07-229

OAAI

The folate cycle enzyme MTHFD2 induces cancer immune evasion through PD-L1 up-regulation

NATURE COMMUNICATIONS

IF15.7

2021-03-2996

OAAI

Nuclear RNR-α antagonizes cell proliferation by directly inhibiting ZRANB3

NATURE CHEMICAL BIOLOGY

IF13.7

2018-08-2721

OAAI

Gelling properties of myosin as affected by L-lysine and L-arginine by changing the main molecular forces and microstructure

L-赖氨酸和L-精氨酸通过改变主要分子力和微观结构影响肌球蛋白的胶凝特性

INTERNATIONAL JOURNAL OF FOOD PROPERTIES

IF3.9

2017-07-1840

OAAI

Effects of L-arginine on the physicochemical and gel properties of chicken actomyosin

INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES

IF8.5

2016-11-0134

PREAI

Substoichiometric Hydroxynonenylation of a Single Protein Recapitulates Whole-Cell-Stimulated Antioxidant Response

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

IF15.6

2014-12-3161

OAAI

Developing Bivalent Ligands to Target CUG Triplet Repeats, the Causative Agent of Myotonic Dystrophy Type 1

JOURNAL OF MEDICINAL CHEMISTRY

IF6.8

2013-11-2158

OAAI

Temporally Controlled Targeting of 4-Hydroxynonenal to Specific Proteins in Living Cells

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

IF15.6

2013-09-1866

OAAI

A Novel CUGexp•MBNL1 Inhibitor with Therapeutic Potential for Myotonic Dystrophy Type 1

ACS CHEMICAL BIOLOGY

IF3.8

2013-03-2069

OAAI

MBNL1-RNA Interactions: Binding-Induced Rna Conformational Changes

BIOPHYSICAL JOURNAL

IF3.1

2012-01-010

OAAI

Selective inhibition of MBNL1-CCUG interaction by small molecules toward potential therapeutic agents for myotonic dystrophy type 2 (DM2)†

NUCLEIC ACIDS RESEARCH

IF13.1

2011-07-1853

OAAI

Highly efficient copper-catalyzed cascade synthesis of quinazoline and quinazolinone derivatives

CHEMICAL COMMUNICATIONS

IF4.2

2008-01-01220

PRE

Characterization of copper binding to the peptide amyloid-β(1-16) associated with Alzheimer's disease

与阿尔茨海默氏病相关的 β 淀粉样肽 (1-16) 与铜结合的表征

IF3.2

2006-04-13105

PREAI